Wright Medical Group, Inc.s

• 5 Possible Takeover Targets in Orthopedic Medical Devices

  By Michael French - January 16, 2012 | Tickers: EXAC, NUVA, TRNX, WMGI, ZMH

  Implanted medical devices are one of the most profitable businesses of the U.S. healthcare industry. In the U.S., about $37B is spent annually on the major orthopedic device procedures. These are mostly artificial knee implants, followed by repairs of bone fractures, spinal fusions, and artificial hip implants.

  Knees are the most frequently replaced joint in the body. The success rate is high: Over 90% of total knee replacements more »

• J.P. Morgan Healthcare Conference Schedule: Day One

  By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

  The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

  I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)